UMU logo

NCMM Director to join Institute for Cancer Research at Oslo University

57 Kjetil Tasken speaker news[2017-11-09) Director of NCMM, Professor Kjetil Taskén, has been appointed as the Head and Director of Institute for Cancer Research Oslo University Hospital (OUH). Professor Taskén will start his new position on 1 January 2018. Kjetil is the founding Director of NCMM, and until September 2017 also held the speaker position for the Nordic EMBL Partnership for Molecular Medicine. Since starting as the Director of the Biotechnology Centre of Oslo in 2003, and becoming Director of NCMM in 2008, he has overseen the growth, evolution and merging of the two organisations into the highly successful research centre that exists today.


 “I have had the pleasure of spending the last 15 years as the Director of the Biotechnology Centre of Oslo, and as Director of  NCMM since its inauguration in 2008,” commented Kjetil Taskén. “Whilst it will never be an ideal time to leave, I feel that with the successful completion of the merger between BiO and NCMM, supported by its excellent Group Leaders, researchers and staff, the centre is probably as strong and robust as it can be. I look forward to seeing how it will develop further in the coming years.”

MIMS is congratulating Kjetil Taskén to his appointment as the Head and Director of Institute for Cancer Research, Oslo University Hospital.
"Both personally and on behalf of the Nordic EMBL Partnership for Molecular Medicine, I wish to thank Kjetil for the great collaboration and all important contributions he has made over the years as a key person during the successful establishment of our partnership", says Bernt Eric Uhlin, Director of MIMS and current Speaker of the Nordic EMBL Partnership for Molecular Medicine.

"We all wish Kjetil the very best in his new role and we are of course looking forward to a continued relationship when he now will be heading an institute that share many of the scientific aims and research areas of the partnership.”
   
Founded in 1954, The Institute for Cancer Research at Oslo University Hospital plays a key role in the field of cancer research, both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master
students included. About 70% of the employees and projects are externally funded.

See https://www.ous-research.no/institute/ for more information.

footer all slides 2014-02-06


Copyright © 2017 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.